ViewRay® to Host Analyst & Investor Meeting at ASTRO in San Diego

Thursday, September 21, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

CLEVELAND, Sept. 20, 2017 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will hold a meeting for analysts and investors

on Monday, September 25, 2017, during the annual meeting of the American Society for Radiation Oncology (ASTRO) in San Diego.

The meeting will include breakfast, a company update

from ViewRay management, and a presentation from M Salim U Siddiqui, MD, PhD, Department of Radiation Oncology at Henry Ford Cancer Institute. Dr. Siddiqui will discuss clinical experiences at Henry Ford Cancer Center with the world's first FDA-Cleared MRI guided linear accelerated-based radiation therapy system.

Event:             ViewRay Analyst & Investor MeetingDate:               Monday, September 25, 2017 Time:               7:00 – 8:30 a.m. PTLocation:        Marriott Marquis, 333 W Harbor Dr. San Diego, CA, South Tower, Level 3

An audio webcast of the presentation will be available on the investor relations section of ViewRay's website at www.viewray.com. A replay of the webcast will be available for 90 days after the date of the presentation.

To attend the live event, please RSVP to Brian Johnston at [email protected].

About ViewRayViewRay®, Inc. (Nasdaq: VRAY) designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian integrates MRI technology, radiation delivery and proprietary software to locate, target and track the position and shape of soft-tissue tumors during radiation. ViewRay believes this combination of enhanced visualization and accuracy will significantly improve outcomes for patients.

ViewRay and MRIdian are registered trademarks of ViewRay, Inc.

View original content:http://www.prnewswire.com/news-releases/viewray-to-host-analyst--investor-meeting-at-astro-in-san-diego-300523050.html

SOURCE ViewRay, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook